| Patent application number | Description | Published |
|---|
| 20080200681 | Processes for preparing palonosetron salts - The present invention provides processes for preparing Palonosetron salts, especially, the hydrochloride salt and intermediates used to prepare Palonosetron salts. | 08-21-2008 |
| 20090247767 | PROCESSES FOR PREPARING SUNITINIB AND SALTS THEREOF - Methods for preparing sunitinib or salts thereof are described using novel intermediates and chemical pathways. One such intermediate is: | 10-01-2009 |
| 20100004449 | CRYSTALLINE FORMS OF ERLOTINIB BASE AND ERLOTINIB HCL - The preparation of crystalline Erlotinib base form G2 is described. This crystalline form can be converted to an Erlotinib salt, such as Erlotinib HCl, which can be used in the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). | 01-07-2010 |
| 20100035354 | PROCESS FOR PREPARING AZACYTIDINE INTERMEDIATE - The present invention provides a processes for preparing 5-Azacytidine, and intermediates thereof. The present invention further provides an analytical method for determining the purity of 5-Azacytidine in a sample. | 02-11-2010 |
| 20100160646 | PROCESSES FOR PREPARING SUNITINIB AND SALTS THEREOF - Methods for preparing sunitinib or salts thereof are described using novel intermediates and chemical pathways. One such intermediate is: | 06-24-2010 |
| 20110009596 | PROCESS FOR THE PREPARATION OF N-PROTECTED-DECYLAMINOETHANAL - Compounds useful in the preparation of telavancin, for example, were prepared. These compounds include decylaminoethanal dialkyl acetals and N-protected decylaminoethanal dialkyl acetals, imidazolidine derivatives, and N-protected-decylaminoethanal. | 01-13-2011 |
